Patents Assigned to Glycobac, LLC
  • Patent number: 11473055
    Abstract: The current teachings are directed to virus free cells lines derived from virus-contaminated starting material, such as an organism or a cell line. Methods for obtaining virus free cell lines obtained from virus-contaminated starting material are also provided. Exemplary virus free cell lines include: cell lines derived from a Spodoptera frugiperda cell line contaminated with Sf-rhabdovirus, wherein the cell lines lack Sf-rhabdovirus; and cell lines derived from a Trichoplusia ni cell line contaminated with an alphanodavirus, wherein the cell line lacks an alphanodavirus.
    Type: Grant
    Filed: November 1, 2016
    Date of Patent: October 18, 2022
    Assignee: GLYCOBAC, LLC
    Inventors: Ajay Maghodia, Christoph Geisler, Donald Jarvis
  • Publication number: 20180355311
    Abstract: The current teachings are directed to novel virus free cells lines derived from virus-contaminated staring material, such as an organism or a cell line. Methods for obtaining virus free cell lines obtained from virus-contaminated starting material are also provided. Exemplary virus free cell lines include: novel cell lines derived from a Spodoptera frugiperda cell line contaminated with Sf-rhabdovirus, wherein the novel cell lines lack Sf-rhabdovirus; and novel cell lines derived from a Trichoplusia ni cell line contaminated with an alphanodavirus, wherein the novel cell line lacks an alphanodavirus.
    Type: Application
    Filed: November 1, 2016
    Publication date: December 13, 2018
    Applicant: Glycobac, LLC
    Inventors: Ajay Maghodia, Christoph Geisler, Donald Jarvis